General Information
BounceWatch is an independent company data service, not affiliated with Enobia Pharma. To contact Enobia Pharma, visit enobia.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Enobia Pharma compare?
A PDF of Enobia Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Enobia Pharma soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Canada Market
Biotechnology
About Enobia Pharma
Business keywords: Enobia, genetic bone disorders, therapies, ENB-0040, enzyme replacement therapy, hyposphosphatasia, subcutaneous, rare disease, tissue non-specific alkaline phosphatase, drug development, biopharmaceuticals
Funding Rounds & Investors (5)
View AllEnobia Pharma Alternatives & Competitors
View All AlternativesDeveloping new treatments for rare metabolic disorders
Empowering Precision Therapies for Rare Neurological Disorders
The next evolution in gene therapy
FAQ About Enobia Pharma
Source: BounceWatch company record for Enobia Pharma, https://bouncewatch.com/company/enobia-pharma, updated 27 October 2024. When citing, please name BounceWatch and link this page.